Andrew Tonini, DO | |
704 Fm 2854, Conroe, TX 77301-2740 | |
(936) 539-4004 | |
(936) 539-3635 |
Full Name | Andrew Tonini |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 12 Years |
Location | 704 Fm 2854, Conroe, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780946566 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | P8738 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Wise Regional Health System | Decatur, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Apogee Medical Group Texas Pa | 9436151792 | 23 |
News Archive
MedImmune and Medarex have announced a collaboration to develop antibodies targeting interferon-alpha and the type I interferon receptor 1.
A new paper to be published in The Journal of Shoulder and Elbow Surgery evaluates the effect that topical benzoyl peroxide (BPO), with chlorhexidine skin preparation, has on the presence of Propionibacterium acnes cultured at the time of shoulder surgery. The authors hypothesized that adding topical BPO, the active ingredient in Clearasil, to the pre-operative skin preparation would reduce the number of positive P. acnes cultures identified during surgery.
Live Webinar for Users and Interested Scientists
Research into the world's worst mass extinction, which led to the loss of 90 per cent of living species 250 million years ago, has found that the historical tragedy also involved some disturbing genetics mutations.
› Verified 5 days ago
Entity Name | Texas Health Physicians Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174573596 PECOS PAC ID: 4385535954 Enrollment ID: O20040323000759 |
News Archive
MedImmune and Medarex have announced a collaboration to develop antibodies targeting interferon-alpha and the type I interferon receptor 1.
A new paper to be published in The Journal of Shoulder and Elbow Surgery evaluates the effect that topical benzoyl peroxide (BPO), with chlorhexidine skin preparation, has on the presence of Propionibacterium acnes cultured at the time of shoulder surgery. The authors hypothesized that adding topical BPO, the active ingredient in Clearasil, to the pre-operative skin preparation would reduce the number of positive P. acnes cultures identified during surgery.
Live Webinar for Users and Interested Scientists
Research into the world's worst mass extinction, which led to the loss of 90 per cent of living species 250 million years ago, has found that the historical tragedy also involved some disturbing genetics mutations.
› Verified 5 days ago
Entity Name | Inpatient Physician Associates Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285696898 PECOS PAC ID: 1759379092 Enrollment ID: O20040504001613 |
News Archive
MedImmune and Medarex have announced a collaboration to develop antibodies targeting interferon-alpha and the type I interferon receptor 1.
A new paper to be published in The Journal of Shoulder and Elbow Surgery evaluates the effect that topical benzoyl peroxide (BPO), with chlorhexidine skin preparation, has on the presence of Propionibacterium acnes cultured at the time of shoulder surgery. The authors hypothesized that adding topical BPO, the active ingredient in Clearasil, to the pre-operative skin preparation would reduce the number of positive P. acnes cultures identified during surgery.
Live Webinar for Users and Interested Scientists
Research into the world's worst mass extinction, which led to the loss of 90 per cent of living species 250 million years ago, has found that the historical tragedy also involved some disturbing genetics mutations.
› Verified 5 days ago
Entity Name | Apogee Medical Group Texas Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558318071 PECOS PAC ID: 9436151792 Enrollment ID: O20070215000533 |
News Archive
MedImmune and Medarex have announced a collaboration to develop antibodies targeting interferon-alpha and the type I interferon receptor 1.
A new paper to be published in The Journal of Shoulder and Elbow Surgery evaluates the effect that topical benzoyl peroxide (BPO), with chlorhexidine skin preparation, has on the presence of Propionibacterium acnes cultured at the time of shoulder surgery. The authors hypothesized that adding topical BPO, the active ingredient in Clearasil, to the pre-operative skin preparation would reduce the number of positive P. acnes cultures identified during surgery.
Live Webinar for Users and Interested Scientists
Research into the world's worst mass extinction, which led to the loss of 90 per cent of living species 250 million years ago, has found that the historical tragedy also involved some disturbing genetics mutations.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Andrew Tonini, DO 6901 Snider Plz, Ste 130, Dallas, TX 75205-5649 Ph: (214) 696-8033 | Andrew Tonini, DO 704 Fm 2854, Conroe, TX 77301-2740 Ph: (936) 539-4004 |
News Archive
MedImmune and Medarex have announced a collaboration to develop antibodies targeting interferon-alpha and the type I interferon receptor 1.
A new paper to be published in The Journal of Shoulder and Elbow Surgery evaluates the effect that topical benzoyl peroxide (BPO), with chlorhexidine skin preparation, has on the presence of Propionibacterium acnes cultured at the time of shoulder surgery. The authors hypothesized that adding topical BPO, the active ingredient in Clearasil, to the pre-operative skin preparation would reduce the number of positive P. acnes cultures identified during surgery.
Live Webinar for Users and Interested Scientists
Research into the world's worst mass extinction, which led to the loss of 90 per cent of living species 250 million years ago, has found that the historical tragedy also involved some disturbing genetics mutations.
› Verified 5 days ago
Justin Grissom, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4015 I H 45 N Ste 100, Conroe, TX 77304 Phone: 936-270-4600 | |
Dr. Samantha Lorel Hinds-campa, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 690 S Loop 336 W, Ste 222, Conroe, TX 77304 Phone: 936-756-6661 Fax: 936-756-6681 | |
John Vernon Peet, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4015 I 45 N, Conroe, TX 77304 Phone: 936-760-7864 | |
Dr. Jason Biscamp, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 690 S Loop 336 W, 3rd Floor, Conroe, TX 77304 Phone: 936-522-4000 Fax: 936-522-4022 | |
Jody Ann Caldwell, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2510 S Loop 336 W, Suite 135, Conroe, TX 77304 Phone: 936-441-8999 | |
Dr. Victoria M Adeleye, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 508 Medical Center Blvd, Ste 200, Conroe, TX 77304 Phone: 936-760-4600 Fax: 936-760-4601 | |
William Patrick Mcdonough, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 605 S Conroe Medical Dr, Conroe, TX 77304 Phone: 936-539-4004 Fax: 936-521-3964 |